Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.55 |
| ▸ | P4HB | P07237 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1067942 | 0.89 | MAPT (0.69) | XDHMAPTCYP3A4ALOX15MEN1 | |
| SCHEMBL30256424 | 0.89 | MAPT (0.69) | XDHMAPTCYP3A4ALOX15MEN1 | |
| SCHEMBL31527939 | 0.89 | MAPT (0.69) | XDHMAPTCYP3A4ALOX15MEN1 | |
| SCHEMBL16887994 | 0.87 | XDH (0.73) | XDHMAPTCYP3A4ALOX15MEN1 | |
| 3,4'-O-Dimethylquercetin SCHEMBL25437986 | 0.86 | CYP3A4 (0.60) | XDHMAPTCYP3A4ALOX15MEN1 | |
| SCHEMBL31162777 | 0.86 | CYP2C9 (0.62) | XDHMAPTCYP3A4ALOX15MEN1 | |
| 3,4'-O-Dimethylquercetin SCHEMBL25437988 | 0.86 | CYP3A4 (0.60) | XDHMAPTCYP3A4ALOX15MEN1 | |
| SCHEMBL31527994 | 0.85 | MEN1 (0.56) | XDHMAPTCYP3A4ALOX15MEN1 | |
| SCHEMBL31162800 | 0.81 | MEN1 (0.56) | XDHMAPTCYP3A4MEN1KMT2A | |
| SCHEMBL26314368 | 0.81 | MEN1 (0.56) | XDHMAPTCYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120114583-A1 | USE OF DIHYDROQUERCETIN AND AT LEAST ONE AMINO ACID TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | HENKEL AG & CO. KGAA (DE) | 2012-05-10 | — | — | US | claimed |
| EP-2456417-A2 | USE OF CARNITINE AND DIHYDROQUERCITIN TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | Henkel AG & Co. KGaA (DE) | 2012-05-30 | — | — | EP | disclosed |
| EP-2456418-A2 | USE OF DIHYDROQUERCETIN AND AT LEAST ONE AMINO ACID TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | Henkel AG & Co. KGaA (DE) | 2012-05-30 | — | — | EP | disclosed |
| US-20120114583-A1 | USE OF DIHYDROQUERCETIN AND AT LEAST ONE AMINO ACID TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | HENKEL AG & CO. KGAA (DE) | 2012-05-10 | — | — | US | disclosed |
| US-20120115944-A1 | USE OF CARNITINE AND DIHYDROQUERCITIN TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | HENKEL AG & CO., KGAA (DE) | 2012-05-10 | — | — | US | disclosed |
| WO-2011009759-A2 | USE OF DIHYDROQUERCETIN AND AT LEAST ONE AMINO ACID TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | HENKEL AG & CO. KGAA (DE) | 2011-01-27 | — | — | WO | disclosed |
| WO-2011009761-A2 | USE OF CARNITINE AND DIHYDROQUERCITIN TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | HENKEL AG & CO. KGAA (DE) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115944-A1 | USE OF CARNITINE AND DIHYDROQUERCITIN TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | SLC25A20, CPT2, CRAT | XDH 717/4885MAPT 2697/4885CYP3A4 3997/4885 |
| US-20120114583-A1 | USE OF DIHYDROQUERCETIN AND AT LEAST ONE AMINO ACID TO POSITIVELY INFLUENCE THE NATURAL PIGMENTATION PROCESS | TYR, TEAD2, TEAD3 | XDH 1277/4885MAPT 289/4885CYP3A4 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.